Cargando…

Citrate anticoagulation realized as CVVHD using a newly designed dialysate solution

Detalles Bibliográficos
Autores principales:	Morgera, S, Schneider, M, Neumayer, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092660/ http://dx.doi.org/10.1186/cc4632

Ejemplares similares

Multicenter prospective observational study on safety and efficacy of regional citrate anticoagulation in CVVHD in the presence of liver failure: the Liver Citrate Anticoagulation Threshold Study (L-CAT)
por: Slowinski, T, et al.
Publicado: (2011)

Super high-flux CVVHD using regional citrate anticoagulation: long-term stability of middle molecule clearance
por: Siebeck, M, et al.
Publicado: (2015)

Pilot study on a regional citrate anticoagulated continuous venovenous hemodiafiltration protocol with variable treatment dose
por: Slowinski, T, et al.
Publicado: (2010)

Recurrent early filter clotting in regional citrate anticoagulated continuous venovenous hemodialysis due to undetected antibodies to heparin-platelet factor 4 complexes
por: Slowinski, T, et al.
Publicado: (2010)

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011)

Elimination rates of electrolytes, vitamins and trace elements during continuous renal replacement therapy with citrate CVVHD: influence of treatment dose
por: Von Freyberg, P, et al.
Publicado: (2014)

Thrombin Generation and Platelet Function in ICU Patients Undergoing CVVHD Using Regional Citrate Anticoagulation
por: Wiegele, Marion, et al.
Publicado: (2021)

Emergency Production and Collection of Dialysate for CVVHD During the COVID-19 Pandemic
por: Singhala, Mohit, et al.
Publicado: (2021)

The pharmacokinetics of tigecycline in critically ill adult patients undergoing CVVHD
por: Rypulak, E, et al.
Publicado: (2015)

Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid
por: Morabito, S, et al.
Publicado: (2012)

Regional citrate anticoagulation with a low-concentration solution in predilution-postdilution CVVH
por: Pistolesi, V, et al.
Publicado: (2012)

Is Anticoagulation Discontinuation Achievable with Citrate Dialysate during HDF Sessions?
por: Dolley-Hitze, Thibault, et al.
Publicado: (2016)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Calcium Repletion and Regional Citrate Anticoagulation in Hemodialysis and Hemodiafiltration: Using Dialysate Calcium to Modify Hypocalcemia
por: Dorie, Justin R., et al.
Publicado: (2021)

Elevation of procalcitonin in chronic dialysed patients
por: Brodska, H, et al.
Publicado: (2008)

Preventing continuous renal replacement therapies (CRRT)-induced hypophosphatemia using a phosphate-containing CRRT solution in the setting of regional citrate anticoagulation
por: Pistolesi, V, et al.
Publicado: (2014)

Heparin-free regional anticoagulation of haemodialysis filters with calcium-free dialysate: is citrate mandatory?
por: Medrano, Chloé, et al.
Publicado: (2021)

Dialyzer clearance of myoglobin with middle molecule filter and low blood flow CVVHD in patients with rhabdomyolysis-associated acute kidney injury
por: Leppanen, I, et al.
Publicado: (2013)

Continuous renal replacement therapy (CVVHD) for acute kidney injury in critical care: incidence and outcome across South West Wales
por: Brown, K, et al.
Publicado: (2014)

Amino acid concentrations in serum, urine and dialysate/ultrafiltrate solutions of continuous venovenous hemodiafiltration patients
por: Lee, JM, et al.
Publicado: (2012)

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
por: Slowinski, Torsten, et al.
Publicado: (2015)

Blood transfusion requirements and filter longevity with regional citrate anticoagulation compared with heparin
por: Burford, E, et al.
Publicado: (2015)

Efficacy and tolerance of sustained low-efficiency dialysis with calcium-free citrate-containing dialysate anticoagulation
por: Vigneron, Clara, et al.
Publicado: (2020)

Renal replacement therapy with high cutoff hemofilters: impact of convection and diffusive on cytokine clearances and protein status
por: Morgera, S, et al.
Publicado: (2004)

Citrate anticoagulation protocol to treat septic shock patients with liver dysfunction in CPFA extracorporeal therapy
por: Ferrari, F, et al.
Publicado: (2012)

Combined use of pumpless extracorporeal lung assist system and continuous renal replacement therapy with citrate anticoagulation in polytrauma patients
por: Atalan, HK, et al.
Publicado: (2013)

Comparison of the efficacy and safety of two regional citrate anticoagulation protocols using acid citrate dextrose A or Prismocitrate 10/2, in patients with acute renal failure undergoing continuous venovenous haemodiafiltration
por: Ooi, EL, et al.
Publicado: (2010)

Effects of two different regional citrate anticoagulation CVVH protocols on acid-base status and phosphate supplementation
por: Morabito, S, et al.
Publicado: (2013)

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

Lipid mediator adosorption with dialyser membrane in patients with septic shock
por: Kase, Y, et al.
Publicado: (2009)

Impact of continuous veno-venous hemodiafiltration with regional citrate anticoagulation on the acid-base balance of critically ill patients
por: Passos, RH, et al.
Publicado: (2006)

Conversion from acetate dialysate to citrate dialysate in a central delivery system for maintenance hemodialysis patients
por: Park, Eun ji, et al.
Publicado: (2019)

The metabolomic differential plasma profile between dialysates. Pursuing to understand the mechanisms of citrate dialysate clinical benefits
por: Broseta, José Jesús, et al.
Publicado: (2022)

Citrate anticoagulation for continuous venovenous haemodiafiltration: the impact of a novel protocol on patients receiving therapy in one regional hospital
por: Highgate, J, et al.
Publicado: (2015)

Stability of citrate and calcium dosing in citrate renal replacement therapy
por: Sadaat, F, et al.
Publicado: (2015)

Impact of CVVHD on pulmonary gas exchange measurement
por: Srámek, V, et al.
Publicado: (1997)

Importance and impact of surveillance of the microbial quality of dialysate and RO water in a tertiary health
por: Ratnamani, M Sri, et al.
Publicado: (2011)

Comparison of pre-filter and post-filter ionised calcium monitoring in continuous veno-venous hemodiafiltration (CVVHD-F) with citrate anti-coagulation
por: Brain, Matthew J., et al.
Publicado: (2017)

Economic argument for citrate haemofiltration
por: Patterson, J, et al.
Publicado: (2011)

Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study
por: François, Karlien, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l7iv5uss35okbf5kq6tjrqa4ie